GB0805862D0 - Method - Google Patents

Method

Info

Publication number
GB0805862D0
GB0805862D0 GBGB0805862.0A GB0805862A GB0805862D0 GB 0805862 D0 GB0805862 D0 GB 0805862D0 GB 0805862 A GB0805862 A GB 0805862A GB 0805862 D0 GB0805862 D0 GB 0805862D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0805862.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioalvo Servicos Investigacao e Desenvolvimento em Biotecnologia SA
Original Assignee
Bioalvo Servicos Investigacao e Desenvolvimento em Biotecnologia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioalvo Servicos Investigacao e Desenvolvimento em Biotecnologia SA filed Critical Bioalvo Servicos Investigacao e Desenvolvimento em Biotecnologia SA
Priority to GBGB0805862.0A priority Critical patent/GB0805862D0/en
Publication of GB0805862D0 publication Critical patent/GB0805862D0/en
Priority to PT09727195T priority patent/PT2271332E/en
Priority to PCT/PT2009/000018 priority patent/WO2009123486A1/en
Priority to EP09727195A priority patent/EP2271332B1/en
Priority to US12/935,869 priority patent/US20110294741A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
GBGB0805862.0A 2008-04-01 2008-04-01 Method Ceased GB0805862D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0805862.0A GB0805862D0 (en) 2008-04-01 2008-04-01 Method
PT09727195T PT2271332E (en) 2008-04-01 2009-04-01 Use of compounds in the treatment of tauopathy
PCT/PT2009/000018 WO2009123486A1 (en) 2008-04-01 2009-04-01 Use of compounds in the treatment of tau-induced cytotoxicities
EP09727195A EP2271332B1 (en) 2008-04-01 2009-04-01 Use of compounds in the treatment of tauopathy
US12/935,869 US20110294741A1 (en) 2008-04-01 2009-04-01 Use of compounds in the treatment of tau-induced cytotoxicities

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0805862.0A GB0805862D0 (en) 2008-04-01 2008-04-01 Method

Publications (1)

Publication Number Publication Date
GB0805862D0 true GB0805862D0 (en) 2008-04-30

Family

ID=39387083

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0805862.0A Ceased GB0805862D0 (en) 2008-04-01 2008-04-01 Method

Country Status (5)

Country Link
US (1) US20110294741A1 (en)
EP (1) EP2271332B1 (en)
GB (1) GB0805862D0 (en)
PT (1) PT2271332E (en)
WO (1) WO2009123486A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011139992A1 (en) * 2010-05-03 2011-11-10 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CN102796164B (en) * 2011-05-24 2014-01-22 首都医科大学 Kyotorphin modified fatty amine/alcohol derivative, and preparation method and application thereof
WO2013049697A1 (en) 2011-09-29 2013-04-04 Mayo Foundation For Medical Education And Research Aromatic-cationic peptides and methods for using same
EP3219207A1 (en) * 2012-09-19 2017-09-20 The Trustees Of The University Of Pennsylvania Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies
WO2019169111A1 (en) 2018-03-02 2019-09-06 The Trustees Of The University Of Pennsylvania [1,2,4]triazolo[1,5-a]pyrimidine compounds and use in stabilizing microtubules
CA3233315A1 (en) * 2021-10-05 2023-04-13 Evonik Operations Gmbh Salts of dipeptides and their uses in cell culture

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6126939A (en) * 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
JP2005517024A (en) * 2002-02-07 2005-06-09 イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム Amino acid sequences that can facilitate permeation across biological barriers
CA2585471A1 (en) * 2004-11-01 2006-05-11 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
US20060166901A1 (en) * 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids

Also Published As

Publication number Publication date
EP2271332A1 (en) 2011-01-12
PT2271332E (en) 2012-09-18
EP2271332B1 (en) 2012-06-20
US20110294741A1 (en) 2011-12-01
WO2009123486A8 (en) 2011-09-29
WO2009123486A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
GB0820927D0 (en) Method
GB0803107D0 (en) Method
GB0818093D0 (en) Method
GB0822836D0 (en) Method
GB0810418D0 (en) Method
GB0806569D0 (en) Methods
GB0807409D0 (en) Method
GB0815428D0 (en) Method
GB0813599D0 (en) Method
GB0807410D0 (en) Method
GB0804981D0 (en) Method
GB0804690D0 (en) Method
EP2309852A4 (en) Novel method
GB0809404D0 (en) Method
GB0811360D0 (en) Methods
ZA201101329B (en) Recarburisation method
ZA201008728B (en) Method
GB0805862D0 (en) Method
GB0813494D0 (en) Method
GB0922037D0 (en) Method
GB0812102D0 (en) Method
GB0806186D0 (en) Method
GB0811166D0 (en) Method
GB0810116D0 (en) Method
GB0816867D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)